发明名称 |
COMBINATION OF GLYCOISOFORMS FOR THE TREATMENT OR PREVENTION OF SEPTICEMIA, TRANSGENIC CELL LINE THAT PRODUCES ERYTHROPOIETIN GLYCOISOFORMS, PHARMACEUTICAL COMPOSITION COMPRISING SAID COMBINATION. |
摘要 |
<p>The invention relates to a combination of erythropoietin glycoisoforms, in which said glycoisoforms can comprise between 4 and 10 sialic acid molecules per molecule of erythropoietin. The aforementioned combination of glycoisoforms can be used for the treatment or prevention of septicemia/sepsis. The invention also relates to a pharmaceutical composition comprising the above-mentioned combination, a cell line that produces a combination of erythropoietin glycoisoforms, methods of obtaining the cell line, a method of producing the combination of glycoisoforms and methods for the treatment and prevention of septicemia/sepsis.</p> |
申请公布号 |
MX2008006159(A) |
申请公布日期 |
2008.10.09 |
申请号 |
MX20080006159 |
申请日期 |
2006.11.07 |
申请人 |
PROTECH PHARMA, S.A. |
发明人 |
LOPEZ, RICARDO AGUSTIN;DAELLI, MARCELO GUSTAVO;PEREIRA BACCI, DARDO ALEXIS;AMADEO, GABRIEL IGNACIO;PEREIRO, MIRIAM PATRICIA;ARTANA, CRISTINA NOEMI;MASKIN, NESTOR;PISTILLO, BERNARDO CESAR;DIDIER, CAROLINA;ETCHEVERRIGARAY, MARINA;KRATJE, RICARDO |
分类号 |
C07K14/505;A61K38/18;C12N15/85 |
主分类号 |
C07K14/505 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|